UTHR vs. SCHG
Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Schwab U.S. Large-Cap Growth ETF (SCHG).
SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Total Return Index. It was launched on Dec 11, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTHR or SCHG.
Key characteristics
| UTHR | SCHG | |
|---|---|---|
| YTD Return | 82.11% | 34.56% |
| 1Y Return | 79.70% | 44.80% |
| 3Y Return (Ann) | 25.50% | 11.31% |
| 5Y Return (Ann) | 35.38% | 21.01% |
| 10Y Return (Ann) | 12.35% | 16.83% |
| Sharpe Ratio | 2.91 | 2.80 |
| Sortino Ratio | 3.67 | 3.58 |
| Omega Ratio | 1.52 | 1.51 |
| Calmar Ratio | 3.24 | 3.87 |
| Martin Ratio | 10.71 | 15.40 |
| Ulcer Index | 7.52% | 3.10% |
| Daily Std Dev | 27.77% | 16.96% |
| Max Drawdown | -93.18% | -34.59% |
| Current Drawdown | -2.33% | 0.00% |
Correlation
The correlation between UTHR and SCHG is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
UTHR vs. SCHG - Performance Comparison
In the year-to-date period, UTHR achieves a 82.11% return, which is significantly higher than SCHG's 34.56% return. Over the past 10 years, UTHR has underperformed SCHG with an annualized return of 12.35%, while SCHG has yielded a comparatively higher 16.83% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTHR vs. SCHG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UTHR vs. SCHG - Dividend Comparison
UTHR has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.40%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.40% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% | 1.09% | 1.07% |
Drawdowns
UTHR vs. SCHG - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for UTHR and SCHG. For additional features, visit the drawdowns tool.
Volatility
UTHR vs. SCHG - Volatility Comparison
United Therapeutics Corporation (UTHR) has a higher volatility of 8.92% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 5.35%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.